Bimatoprost-Mepha Plus Collirio 스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

bimatoprost-mepha plus collirio

mepha pharma ag - bimatoprostum, timololum - collirio - bimatoprostum 0,3 mg, timololum 5 mg timololi malea, conserv.: benzalkonii chloridum, excipiens ad una soluzione per 1 ml. - il glaucoma - synthetika

Zeposia 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunosoppressori - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

ECBIRIO 이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

ecbirio

sifi s.p.a. - timololo, associazioni - timololo, associazioni

LIFOG 이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

lifog

zaklady farmaceutyczne polpharma sa - latanoprost - latanoprost

BITIFRIN 이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

bitifrin

zaklady farmaceutyczne polpharma sa - timololo, associazioni - timololo, associazioni